Summa Equity to acquire a majority stake in STIM from Nordly.

Summa Equity, a thematic investment firm, agreed to acquire a majority stake in STIM, a fish health products and service supplier, from Nordly, a specialist in pharmaceuticals and aquaculture industries. Financial terms were not disclosed. “I am convinced that Summa is the right strategic and long-term partner for us. They recognize that our employees' expertise and efforts is the bedrock of this company. With Summa on our side, I am confident that STIM can become the world leader within sustainability and health, not just within the salmon industry, but for the seafood industry as a whole. There is a huge demand for advisory services within this sector, and that is something we have our eyes on,” Jim-Roger Nordly, STIM Chairman and Founder.